Abstract

BackgroundThe main purpose of performing radiofrequency catheter ablation (RFCA) in atrial fibrillation (AF) patients is to improve the quality of life (QoL) and alleviate AF-related symptoms. We aimed to determine the qualitative and quantitative effects of RFCA on the QoL in AF patients.MethodsWe performed a systemic review and meta-analysis using a random effects model. We searched for the studies that reported the physical component summary score (PCS) and mental component summary score (MCS) of the short form-36, a validated system to assess and quantify the QoL, before and after RFCA in AF patients. PCS and MCS are T-scores with a mean of 50 and standard deviation of 10.ResultsOf the 470 studies identified through systematic search, we included 13 studies for pre-RFCA vs. the post-RFCA analysis and 5 studies for treatment success vs. AF recurrence analyses. In the pre-RFCA vs. post-RFCA analysis, RFCA was associated with a significant increase in both the PCS (weighted mean difference [WMD] = 6.33 [4.81–7.84]; p < 0.001) and MCS (WMD = 7.80 [6.15–9.44]; p < 0.001). The ΔPCS (post-RFCA PCS–pre-RFCA PCS) and ΔMCS values were used for the treatment success vs. AF recurrence analysis. Patients with successful ablation had a higher ΔPCS (WMD = 7.46 [4.44–10.49]; p < 0.001) and ΔMCS (WMD = 7.59 [4.94–10.24]; p < 0.001).ConclusionsRFCA is associated with a significant increase in the PCS and MCS in AF patients. Patients without AF recurrence after RFCA had a better improvement in the PCS and MCS than patients who had AF recurrence.

Highlights

  • Antiarrhythmic drug therapy is considered as a first line treatment for the management of atrial fibrillation (AF)

  • Of the 470 studies identified through systematic search, we included 13 studies for preRFCA vs. the post-radiofrequency catheter ablation (RFCA) analysis and 5 studies for treatment success vs. AF recurrence analyses

  • The ΔPCS and ΔMCS values were used for the treatment success vs. AF recurrence analysis

Read more

Summary

Introduction

Antiarrhythmic drug therapy is considered as a first line treatment for the management of atrial fibrillation (AF). Several trials have studied the efficacy of RFCA in AAD naive patients [8,9,10] These studies have demonstrated a superiority of RFCA in maintaining sinus rhythm in AF patients, current available trials indicate that both AAD and RFCA do not reduce the mortality or serious complications such as stroke [1, 6, 9,10,11]. Reducing AF-related symptoms and improving the quality of life (QoL) is the cornerstone of AF treatment [12, 13]. The main purpose of performing radiofrequency catheter ablation (RFCA) in atrial fibrillation (AF) patients is to improve the quality of life (QoL) and alleviate AF-related symptoms. We aimed to determine the qualitative and quantitative effects of RFCA on the QoL in AF patients

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call